Steven Cohen Bio Rad Laboratories, Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 34,604 shares of BIO stock, worth $9.14 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,604
Previous 34,604
-0.0%
Holding current value
$9.14 Million
Previous $8.43 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding BIO
# of Institutions
438Shares Held
19.5MCall Options Held
12.7KPut Options Held
14.4K-
First Eagle Investment Management, LLC2.52MShares$665 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.91MShares$505 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$410 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$232 Million0.05% of portfolio
-
Veritas Asset Management LLP863KShares$228 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.51B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...